Bangladesh vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Bangladesh
43.54
in 2021
Solomon Islands
45.52
in 2021
Bangladesh rank
121st
Solomon Islands rank
118th
The number of people with susceptibility test result for rifampicin over time
- Bangladesh
- Solomon Islands
How they compare
Solomon Islands currently reports 45.52 against 43.54 in Bangladesh, a difference of 1.98.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bangladesh ahead.
Bangladesh ranks 121st and Solomon Islands ranks 118th of 146 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Bangladesh | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.1 | 0 | 26.1 | Bangladesh |
| 2020s | 39.25 | 55.88 | 16.63 | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bangladesh or Solomon Islands?
- Solomon Islands, at 45.52 against 43.54 in Bangladesh as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bangladesh and Solomon Islands?
- 1.98, with Solomon Islands ahead.
- How many years of comparable data are there for Bangladesh and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Bangladesh and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 121st and Solomon Islands ranks 118th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.